Treatment Period and Long-term Effect of Functional Electric Stimulation (FES) for Bruxism
NCT ID: NCT00807430
Last Updated: 2009-10-21
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
48 participants
INTERVENTIONAL
2009-02-28
2009-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment Period and Long-term Efficacy of Functional Electrical Stimulation (FES) on Sleep Bruxism
NCT01005511
Changes in Electromyographic Activity in Aligner Treatment of Adult Patients With and Without Nocturnal Bruxism
NCT06343194
Comparison of Two Exercise Therapy Protocols in Patients With Bruxism
NCT05555628
Analysis of Occlusal Force Distribution in Digital and Conventional Occlusal Splint
NCT06652217
Interest of the BRUXENSE Occlusal Splints for Bruxism Diagnosis: a Feasibility Study
NCT03363204
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
24 patients receiving active treatment
Grindcare (Active)
Active treatment
2
Placebo treatment
Grindcare (Placebo - the device is not activated)
Placebo treatment
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Grindcare (Active)
Active treatment
Grindcare (Placebo - the device is not activated)
Placebo treatment
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* 18 years or older
* Fulfill the RDC-criteria for myofascial TMD diagnose (group 1a or 1b)
* Average pain more that 3 on a Visual Analog scale (VAS) in the baseline period
Exclusion Criteria
* Daily use of pain medication, e.g. prophylaxis against migraine or headache.
* Patients who are using occlusal splints in the treatment period.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Medotech A/S
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aarhus University Dentist School
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Troels B Mortensen
Role: STUDY_DIRECTOR
Medotech A/S
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Odontologisk Institut
Aarhus C, , Denmark
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TMD-00
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.